Year |
Citation |
Score |
2022 |
Zamanian C, Bhandarkar AR, Monie DD, Moinuddin FM, Vile RG, Quiñones-Hinojosa A, Bydon M. Systems neuroimmunology: a review of multiomics methodologies to characterize neuroimmunological interactions in spinal and cranial diseases. Neurosurgical Focus. 52: E9. PMID 35104798 DOI: 10.3171/2021.11.FOCUS21571 |
0.446 |
|
2021 |
Wen T, Barham W, Li Y, Zhang H, Gicobi JK, Hirdler JB, Liu X, Ham H, Peterson Martinez KE, Lucien F, Lavoie RR, Li H, Correia C, Monie DD, An Z, et al. NKG7 is a T-cell intrinsic therapeutic target for improving antitumor cytotoxicity and cancer immunotherapy. Cancer Immunology Research. PMID 34911739 DOI: 10.1158/2326-6066.CIR-21-0539 |
0.452 |
|
2021 |
Monie DD, Correia C, Zhang C, Ung CY, Vile RG, Li H. Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas. Scientific Reports. 11: 11198. PMID 34045642 DOI: 10.1038/s41598-021-90718-1 |
0.511 |
|
2021 |
Wyles SP, Monie DD, Paradise CR, Meyer FB, Hayden RE, Terzic A. Emerging workforce readiness in regenerative healthcare. Regenerative Medicine. PMID 33622054 DOI: 10.2217/rme-2020-0137 |
0.352 |
|
2021 |
Monie DD, Bhandarkar AR, Parney IF, Correia C, Sarkaria JN, Vile RG, Li H. Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma. Neurosurgical Focus. 50: E10. PMID 33524942 DOI: 10.3171/2020.12.FOCUS20855 |
0.506 |
|
2020 |
Monie DD, Meyer FB. Ependymal Petechial Hemorrhages in Bacterial Meningitis. Mayo Clinic Proceedings. 95: 1940-1941. PMID 32861336 DOI: 10.1016/j.mayocp.2020.07.005 |
0.316 |
|
2020 |
Evgin L, Huff AL, Wongthida P, Thompson J, Kottke T, Tonne J, Schuelke M, Ayasoufi K, Driscoll CB, Shim KG, Reynolds P, Monie DD, Johnson AJ, Coffey M, Young SL, et al. Oncolytic virus-derived type I interferon restricts CAR T cell therapy. Nature Communications. 11: 3187. PMID 32581235 DOI: 10.1038/S41467-020-17011-Z |
0.539 |
|
2017 |
Monie DD, DeLoughery EP. Pathogenesis of thrombosis: cellular and pharmacogenetic contributions Cardiovascular Diagnosis and Therapy. 7. PMID 29399533 DOI: 10.21037/Cdt.2017.09.11 |
0.302 |
|
2011 |
Oh U, McCormick MJ, Datta D, Turner RV, Bobb K, Monie DD, Sliskovic DR, Tanaka Y, Zhang J, Meshulam J, Jacobson S. Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease. Blood. 117: 3363-9. PMID 21212284 DOI: 10.1182/Blood-2010-10-306571 |
0.328 |
|
2011 |
McCormick M, Oh U, Datta D, Turner R, Bobb K, Monie D, Sliskovic DR, Zhang J, Meshulam J, Jacobson S. NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis Retrovirology. 8: 1-1. DOI: 10.1186/1742-4690-8-S1-A117 |
0.333 |
|
1999 |
Vath GM, Earhart CA, Monie DD, Iandolo JJ, Schlievert PM, Ohlendorf DH. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry. 38: 10239-46. PMID 10441117 DOI: 10.1021/Bi990721E |
0.4 |
|
Show low-probability matches. |